While this is a significant limitation, we addressed it analytically by performing a study-level meta-regression using oral corticosteroid prevalence, which revealed a significant trend, suggesting that higher oral corticosteroid exposure may amplify the ICS-associated risk.
← all excerpts
Evaluating inhaled corticosteroids' impact on osteoporosis and fracture risk in COPD patients: a real-world evidence-based systematic review and meta-analysis.
1
—
—